Clinical Outcome of Thrombolytic Therapy

The prevalence of ischemic heart diseases, especially acute myocardial infarction and its incidence has increased at early ages, and therapies in acute stages of myocardial infarction play a vital role in the prognosis and quality of patients’ life. Fibrinolytic treatment of acute myocardial infarction must be performed as early as the disease begins. Since the reduction of pre-hospital delay is difficult, it is emphasized. This study aims to evaluate the clinical outcome of thrombolytic therapy in patients with acute myocardial infarction who referred to Ayatollah Taleghani Educational-Medical Center of Urmia in 2013-2016.